Animal models of pain: Diversity and benefits

• Published in: Journal of neuroscience methods 2021-01, Vol.348, p.108997-108997, Article 108997
• Main Authors: Abboud, Cynthia, Duveau, Alexia, Bouali-Benazzouz, Rabia, Massé, Karine, Mattar, Joseph, Brochoire, Louison, Fossat, Pascal, Boué-Grabot, Eric, Hleihel, Walid, Landry, Marc
• Format: Article
• Language: English
• Subjects: Animal models; Inflammatory pain; Life Sciences; Neurobiology; Neurons and Cognition; Neuropathic pain; Pain; Pain behaviour; Preclinical research
• ISSN: 0165-0270; 1872-678X
• DOI: 10.1016/j.jneumeth.2020.108997

•Evaluation tools to assess chronic pain and its comorbidities•inventory of a large diversity of pain models including rodents, non-human primates pain models and simple organisms•Focus on inflammatory and neuropathic pain models•Limitations of the predictive validity of animal models of pain•Translational successes from animal model studies to develop new analgesics Chronic pain is a maladaptive neurological disease that remains a major health problem. A deepening of our knowledge on mechanisms that cause pain is a prerequisite to developing novel treatments. A large variety of animal models of pain has been developed that recapitulate the diverse symptoms of different pain pathologies. These models reproduce different pain phenotypes and remain necessary to examine the multidimensional aspects of pain and understand the cellular and molecular basis underlying pain conditions. In this review, we propose an overview of animal models, from simple organisms to rodents and non-human primates and the specific traits of pain pathologies they model. We present the main behavioral tests for assessing pain and investing the underpinning mechanisms of chronic pathological pain. The validity of animal models is analysed based on their ability to mimic human clinical diseases and to predict treatment outcomes. Refine characterization of pathological phenotypes also requires to consider pain globally using specific procedures dedicated to study emotional comorbidities of pain. We discuss the limitations of pain models when research findings fail to be translated from animal models to human clinics. But we also point to some recent successes in analgesic drug development that highlight strategies for improving the predictive validity of animal models of pain. Finally, we emphasize the importance of using assortments of preclinical pain models to identify pain subtype mechanisms, and to foster the development of better analgesics.